Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer

NCT00217737 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

2431

Enrollment

NIH

Sponsor class

Conditions

Colon Adenocarcinoma
Stage IIA Colon Cancer AJCC v7
Stage IIB Colon Cancer AJCC v7
Stage IIC Colon Cancer AJCC v7

Interventions

BIOLOGICAL: Bevacizumab
DRUG: Fluorouracil
DRUG: Leucovorin
DRUG: Oxaliplatin

Sponsor

National Cancer Institute (NCI)